Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Newsroom
In the News

November 13, 2014
Bioniche Life Sciences Inc. Announces Results of Annual General Meeting of Shareholders SHAREHOLDERS

November 12, 2014
Bioniche Life Sciences Inc. Reports MCNA Update & First Quarter Results

Investors

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.


Newsroom

Archived Releases

November 2003

04/11/03
Bioniche Reports First Quarter Fiscal 2004 Results

October 2003

21/10/03
Nebraska Research Studies Confirm Efficacy of E. coli Vaccine

September 2003

15/09/03
Bioniche Reports 2003 Year-End Results

09/09/03
Bioniche Completes Second Tranche of $13.5 Million Financing

August 2003

15/08/03
Preliminary Results of North American Cystistat® Trial Announced

July 2003

14/07/03
Bioniche Pharma Group Receives FDA Approval For Cardiovascular Sterile Injectable

June 2003

17/06/03
Two Research Studies on Canadian E. coli Vaccine Presented at VTEC International Symposium in Edinburgh

06/06/03
Bioniche Announces Private Financing Completion

03/06/03
Bioniche Ranked Among Canada’s Top 100 Fastest Growing Companies

03/06/03
Bioniche Ranked Among Canada’s Top 100 Fastest Growing Companies

02/06/03
Results of Independent European Study on Cystistat®

May 2003

26/05/03
Bioniche Life Sciences Inc. Completes $13.5 Million Financing

23/05/03
Third Quarter Results

22/05/03
Bioniche Reaches Agreement with Fidia Farmaceutici S.p.A.

April 2003

30/04/03
Urology Platform Presented at American Urology Association Annual Meeting

March 2003

18/03/03
Bioniche Life Sciences Announces Additional Bladder Cancer Results

February 2003

17/02/03
Bioniche Posts 40% Consolidated Revenue Increase

January 2003

08/01/03
Bioniche Pharma Receives FDA Approval For Promethazine 10ml

December 2002

13/12/02
Bioniche Receives FDA Approval For Urology Product

October 2002

31/10/02
Bioniche Announces Webcast of Fiscal 2003 First Quarter Results Conference Call

30/10/02
Bioniche Life Sciences Announces First Quarter 2003 Results

30/10/02
Bioniche Launches Amiodarone I.V. Vials in the U.S. with Baxter

17/10/02
Bioniche Receives FDA Approval For Sterile Injectable

September 2002

30/09/02
Bioniche Presents Positive anti-cancer data in leukemia and lymphoma

24/09/02
Bioniche Makes Four Presentations At Prestigious SIU Congress

05/09/02
Bioniche Life Sciences Reports 2002 Year-End Results

03/09/02
Bioniche Defends Patent Infringement Litigation

July 2002

23/07/02
Bioniche Receives FDA Tentative Approval For Sterile Injectable

17/07/02
Bioniche Receives FDA Approval for EDTA Injection

08/07/02
“Bioniche Animal Health” New Name for Vetrepharm

03/07/02
Bioniche Appoints Martin J. Warmelink New President for Global Animal Health Business

June 2002

14/06/02
Bioniche Hires Dr. Marc Rivière as Senior Vice President and Chief Medical Officer

13/06/02
Bioniche Life Sciences Appoints New Member to its Board

10/06/02
Bioniche Presents Positive Study Findings on Breast Cancer

May 2002

27/05/02
Bioniche Reports Positive 12-Month Results From Bladder Cancer Trial

24/05/02
Bioniche Life Sciences Inc. Receives Ontario Global Traders Award

08/05/02
Bioniche Life Sciences Announces Third Quarter 2002 Results

01/05/02
Bioniche Announces Webcast of Third Quarter 2002 Conference Call

April 2002

19/04/02
Bioniche Subsidiary Receives C$1.8 Million Investment

February 2002

26/02/02
Bioniche Life Sciences signs agreement with US pharmaceutical company

20/02/02
Bioniche Life Sciences Signs Agreement at Team Canada Trade Mission

19/02/02
Bioniche Life Sciences Receives U.S. FDA Approval For Sterile Injectable

06/02/02
Bioniche Life Sciences Reports Strong Second Quarter and First Half 2002 Results

05/02/02
Bioniche Life Sciences Receives U.S. Patent for Company's Lead Technology

04/02/02
Bioniche Life Sciences Strengthens Its Intellectual Property Portfolio With Key U.S. Patent

January 2002

31/01/02
Bioniche Life Sciences Receives Key European Patent For MCC

December 2001

18/12/01
Bioniche Life Sciences Inc. Receives $1.4 Million Funding From Government of Ontario

13/12/01
Bioniche Life Sciences Inc. and Chiesi Sign Suplasyn Distribution Agreement for France

November 2001

01/11/01
Bioniche Life Sciences Inc. Funds $4 Million Research Chair in Food Safety

01/11/01
Bioniche Life Sciences Inc. Acquires Production Facility in Montreal

October 2001

30/10/01
Bioniche Life Sciences Inc. Reports Strong First Quarter Results

05/10/01
Bioniche Life Sciences Inc. Makes Acquisition in Animal Health Sector

05/10/01
Bioniche Life Sciences Inc. Makes Acquisition in Animal Health Sector

September 2001

24/09/01
Bioniche Life Sciences Inc. Announces 2001 Year-End Financial Results

24/09/01
Bioniche Life Sciences Inc. Announces 2001 Year-End Financial Results

July 2001

24/07/01
Bioniche Life Sciences Inc. and Technology Partnerships Canada Hold Ceremony to mark $17.2 Million Investment

24/07/01
Bioniche Life Sciences Inc. and Technology Partnerships Canada Hold Ceremony to mark $17.2 Million Investment

04/07/01
Bioniche Life Sciences Inc. Completes $10 Million Financing

04/07/01
Bioniche Life Sciences Inc. Completes $10 Million Financing

June 2001

28/06/01
Bioniche Life Sciences Inc. Completes First Tranche of $10 Million Financing

25/06/01
Bioniche Reports Phase I/II Bladder Cancer Trial Results

25/06/01
Bioniche Reports Phase I/II Bladder Cancer Trial Results

May 2001

28/05/01
Bioniche Life Sciences Inc. Announces 2001 Third Quarter Financial Results

28/05/01
Bioniche Life Sciences Inc. Announces 2001 Third Quarter Financial Results

28/05/01
Bioniche Life Sciences Inc. Announces 2001 Third Quarter Financial Results

April 2001

19/04/01
Bioniche Life Sciences Marks Progress in Global Expansion

19/04/01
Bioniche Life Sciences Marks Progress in Global Expansion

March 2001

13/03/01
Bioniche Life Sciences Completes Major European Distribution Network with New Partner

13/03/01
Bioniche Life Sciences Completes Major European Distribution Network with New Partner

07/03/01
Bioniche Life Sciences Enters North American Urology Collaboration

February 2001

22/02/01
Bioniche Life Sciences Inc. Announces Second Quarter 2001 Financial Results

January 2001

17/01/01
Bioniche Announces Approval to Begin Phase I Study of MCC as Treatment for Prostate Cancer

December 2000

19/12/00
Bioniche Reports Interim Bladder Cancer Trial Results - An encouraging 57% positive response rate demonstrated -

05/12/00
Bioniche Recognized as one of Canada’s Top-Ten Emerging Biotech Companies

November 2000

28/11/00
Bioniche Life Sciences Inc. Announces 2001 First Quarter Financial Results

16/11/00
Bioniche Life Sciences Provides Preclinical Scientific Update

October 2000

30/10/00
Bioniche Life Sciences Announces New Distribution Agreements for Suplasyn

September 2000

28/09/00
Bioniche Life Sciences' Cystistat® Gets Marketing Boost in Germany

20/09/00
New E.coli vaccine to be produced in Canada

19/09/00
Bioniche Life Sciences Inc. Announces Year-end Results

13/09/00
Bioniche Presents Important New Anti-Cancer Findings at the Hyaluronan 2000 International Meeting

07/09/00
Bioniche Receives Approval for Expanded Indications in Europe for Cystistat®

August 2000

31/08/00
Bioniche Presents Leukemia Study Findings at 28th World Congress of The International Society Of Hematology

14/08/00
Bioniche’s MCC Shows Broad Activity Against Prostate Cancer in Preclinical Testing

June 2000

28/06/00
Bioniche Life Sciences Inc. announces Italian distribution agreement for Cystistat®

07/06/00
Bioniche Life Sciences Inc. Discovers New Class of Molecules with Potent Anti-Cancer Activity

05/06/00
Bioniche Life Sciences Inc.'s Animal Health Subsidiary Divests Autogenous Bacterin Division - Divestiture Allows Vetrepharm to Focus on Major Pipeline Products

May 2000

10/05/00
Marketing opportunities expand for Bioniche Life Sciences' Cystistat® - Company Receives Approval for Expanded Indications in Canada

February 2000

02/02/00
Bioniche Life Sciences Inc. announces completion of $13 million financing

January 2000

27/01/00
Bioniche Life Sciences Inc. announces licensing agreement with Merckle for German market

10/01/00
Bioniche Life Sciences Inc. announces financing in pharma division

November 1999

29/11/99
Bioniche Life Sciences Inc. announces first quarter results

15/11/99
Bioniche Life Sciences Inc. Announces Year-End Results for Bioniche Inc.

August 1999

19/08/99
Bioniche Announces IND Approval


Newsroom

Categories:
All Releases
Archived Releases
Animal Health
Corporate
Financial
Human Health
One Health

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy